A molecular genotyping test for high-risk HPV detected approximately six times more infections than conventional Pap smear results among women in Brasília, according to a study presented at the Eurogin 2026 conference.
A recent study revealed that a molecular genotyping test for high-risk human papillomavirus (HPV) identified nearly six times the infections compared to traditional Pap smears among women in Brasília. This research was conducted by a multidisciplinary team consisting of institutions like the Butantan Institute and Campo Real University, analyzing 753 cervical samples collected from women aged 18 to 79 in various locations throughout the Federal District. The results were presented at the Eurogin 2026 conference held in Austria.
The findings highlighted that while the DNA genotyping for HPV showed a positivity rate of 16.6% in the samples analyzed, only 2.92% of the samples revealed cellular alterations through the Pap test. This significant disparity underscores the potential benefits of utilizing DNA testing methods for more accurate detection of HPV infections, as traditional Pap smears may miss a considerable number of cases, especially in a population where awareness of HPV and its risks is still developing.
By presenting these results at an international conference, researchers aim to advocate for a shift in screening approaches for HPV in Brazil and potentially influence public health policies. The data supports the urgency of adopting advanced testing methods to ensure better health outcomes for women, shedding light on the need for increased awareness and early detection strategies in combating HPV-related health issues.
